JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8%
Mon, 1 Jun

JUBILANT LIFE SCIENCES has announced its results for the quarter ended March 2020. Here is a detailed performance review of the same:

JUBILANT LIFE SCIENCES Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-19*
3
Dec-19*
3
Mar-20*
QoQ ChangeYoY Change
Net SalesRs m23,85623,15223,9143.3%0.2%
Other incomeRs m6660194222.4%195.4%
TurnoverRs m23,92223,21224,1093.9%0.8%
ExpensesRs m20,27618,07818,5482.6%-8.5%
Gross profitRs m1,1014,7285,36613.5%387.6%
DepreciationRs m9501,1351,28913.6%35.7%
InterestRs m616720712-1.2%15.5%
Profit before taxRs m-4002,9333,56021.4%
TaxRs m6078999556.1%57.3%
Profit after taxRs m-1,0072,0342,60528.1%
Gross profit margin%4.620.422.4
Effective tax rate%-151.830.726.8
Net profit margin%-4.28.810.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 0.2% on a year-on-year (YoY) basis. The expenses were down by 8.5% YoY during the same period.
  • The company's operating profit increased by 387.6% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 22.4% in 4QFY20 as against 4.6% in 4QFY19.
  • Depreciation charges increased by 35.7% and finance costs increased by 15.5% YoY, respectively.
  • Other income increased by 195.4% YoY during the quarter.
  • Net profit for the quarter increased by 358.8% YoY. Net profit margins during the quarter increased from -4.2% in 4QFY19 to 10.8% in 4QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 3.3% on a quarter-on-quarter (QoQ) basis. The expenses were up by 2.6% QoQ during the same period.
  • The company's operating profit increased by 13.5% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 22.4% in 4QFY20 as against 20.4% in 3QFY19.
  • Net profit for the quarter increased by 28.1% QoQ, while net profit margins increased from 8.8% in 3QFY19 to 10.8% in 4QFY20.

To see how JUBILANT LIFE SCIENCES has performed over the last eight quarters,please visit here.

Revealed: How Fund Managers Spot Winning Stocks

JUBILANT LIFE SCIENCES Share Price Performance

Over the last one year,JUBILANT LIFE SCIENCES share price has moved down from Rs 495.4 to Rs 464.4, registering a Loss of Rs 31.1 or around 6.3%.

Meanwhile, the S&P BSE OIL & GAS Index is trading at Rs 12,024.8 (up 1.6%). Over the last one year it has moved down from 15,734.4 to 12,024.8, a gain of 3,710 points (down 23.6%).

Overall, the S&P BSE SENSEX is down 15.8% over the year.

Current Valuations

At the current price of Rs 464.4, the price to earnings (P/E) ratio of JUBILANT LIFE SCIENCES stands at 8.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.5 times.

Equitymaster requests your view! Post a comment on "JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8%". Click here!

  

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage(Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors(Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC(Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend(Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today(Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Jul 23, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 5-YR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS